Skip to main content

Marizyme

  • About
      • Back
      • Overview
      • Executive Management
      • Board of Directors
      • Corporate Governance
  • Products
      • Back
      • Overview
      • DuraGraft®
      • Krillase®
      • MATLOC™ Platform
  • Investors
  • Contact
      • Back
      • Contact Us
  • Sign Up
adobe stock 229690447 preview

Products
Overview

Innovative technologies and a diverse product pipeline help de-risk product specific execution. Marizyme has focused on large markets including CABG surgery, fat grafting, pet health, and CKD. Access into any and all of these markets provide significant clinical and economic opportunity.

ProductIndicationResearchDevelopmentClinical
Trial
CE MarkedFDA
Approval
group 4549 Vascular Grafts Storage Vascular and Flushing Solution during CABG Surgery        
group 4550 Pet Health - Dental        
group 4550 Measurement of Urine Albumin and Creatinine (ACR)        
group 4550 Measurement of Urine ACR and Blood-Based eGFR        

Marizyme, Inc. is a multi-technology biomedical company dedicated to the development and commercialization of medical technologies that improve patient health outcomes.

 

Investors

  • Stock Info
  • SEC Filings
  • Corporate Governance

Contact

  • Back
  • Contact Us
  • Sign Up
  • Accessibility
 

Get In Touch 

noun map 223137 555 Heritage Drive, Ste. 205,
Jupiter, FL 33458
noun phone 4637987 (561) 935-9955
noun email 3083073 info@marizyme.com 
Marizyme
© Copyright - 2023 Marizyme Inc. | All Rights Reserved | Website by Sandman Media Inc